Do antidepressants affect motivation in conditioned place preference?

[1]  R. Sewell,et al.  Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine. , 2000, European journal of pharmacology.

[2]  S. Cheetham,et al.  A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents , 1998, British journal of pharmacology.

[3]  E. Esposito,et al.  Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area , 1998, Brain Research Bulletin.

[4]  M. Scheinbaum,et al.  Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines. , 1998, Journal of clinical psychopharmacology.

[5]  R. Sewell,et al.  The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds , 1998, British journal of pharmacology.

[6]  C. Nemeroff,et al.  Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.

[7]  M. Collu,et al.  Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats. , 1997, European journal of pharmacology.

[8]  M. Collu,et al.  Fluoxetine‐induced conditioned place preference: A preliminary study , 1997, Synapse.

[9]  M. Stock,et al.  Sibutramine: a review of the pharmacology of a novel anti-obesity agent. , 1997, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[10]  E. Esposito,et al.  Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area , 1995, British journal of pharmacology.

[11]  P. Spencer,et al.  Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. , 1995, European journal of pharmacology.

[12]  E. Esposito,et al.  Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. , 1994, The Journal of pharmacology and experimental therapeutics.

[13]  Pagliaro La,et al.  Fluoxetine abuse by an intravenous drug user. , 1993 .

[14]  P. D’Aquila,et al.  Role of the mesolimbic dopamine system in the mechanism of action of antidepressants. , 1992, Pharmacology & toxicology.

[15]  H. Fibiger,et al.  Chronic desipramine enhances the effect of locally applied amphetamine on interstitial concentrations of dopamine in the nucleus accumbens. , 1991, European journal of pharmacology.

[16]  H. Fibiger,et al.  Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. , 1991, European journal of pharmacology.

[17]  D. Jd.  A case of amitriptyline abuse. , 1990 .

[18]  G. Gessa,et al.  Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. , 1990, European journal of pharmacology.

[19]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[20]  Mariusz Papp.  Differential effects of short- and long‐term antidepressant treatments on the food‐induced place preference conditioning in rats , 1989, Behavioural Pharmacology.

[21]  M. Papp.  Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats , 1988, Pharmacology Biochemistry and Behavior.

[22]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Beaudet,et al.  Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons , 1987, Brain Research.

[24]  M. L. de Ceballos,et al.  Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat. , 1985, European journal of pharmacology.

[25]  F. Borsini,et al.  Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' test in rats. , 1985, European journal of pharmacology.

[26]  E. Richelson,et al.  Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. , 1984, European journal of pharmacology.

[27]  P. Willner.  Dopamine and depression: A review of recent evidence. I. Empirical studies , 1983, Brain Research Reviews.

[28]  A. Phillips,et al.  Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions , 1982, Brain Research.

[29]  C. Schuster,et al.  Abuse liability assessment of sibutramine, a novel weight control agent , 2000, Psychopharmacology.

[30]  E. Richelson,et al.  Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. , 1993, Life sciences.

[31]  G. Koob.  Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[32]  P. Willner.  Animal models of depression: an overview. , 1990, Pharmacology & therapeutics.

[33]  D. Charney,et al.  Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects. , 1989, Life sciences.

[34]  H. Meltzer,et al.  Psychopharmacology : the third generation of progress , 1987 .

[35]  H. Hall.  Relationships between receptor affinities of different antidepressants and their clinical profiles , 1983 .

[36]  S. Dahl,et al.  Clinical Pharmacology in Psychiatry , 1981, Palgrave Macmillan UK.